- The trend backdrop is active with a 5-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
1548
HKG
Week ended 07 Aug 2026
Weekly Investor Report
Genscript Biotech Corporation · Healthcare · Biotechnology
Latest close
22.98 HKD
27.2%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 71.2% above the Trend Line and sits at 99.7% of its 52-week range. The latest completed week returned 27.2%, after a 66.0% four-week move. The latest news-sentiment score is 51/100. Near-term considerations: price is close to its 52-week high.
Setup score
72
out of 100
Latest Close
22.98 HKD
7 Aug 2026
1W Return
27.2%
latest completed week
4W Return
66.0%
short-term follow-through
12W Return
63.4%
quarterly tape
Trend Breadth
38.5%
20 of 52 weeks active
Volume Ratio
2.8x
vs 13-week average
- Activity pressure is weak, so confirmation is not yet broad enough.
- 1 reversal markers appear in the recent smart-money tape.
- Recent volatility is running well above the one-year baseline.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
27.2%
Latest completed week; four-week move 66.0%.
Indicator stack
38/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
51/100
20 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 71.2% above the Trend Line and sits at 99.7% of its 52-week range. The latest completed week returned 27.2%, after a 66.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3812-week average 0.31
12-week confirmation
Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.38Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers
No recent accumulation markers. 1 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 66.0% over four weeks, 63.4% over 12 weeks, and 35.6% over one year. The current trend has remained active for 5 consecutive weeks.
Performance by holding period
Active trend streak5 weeks
Active weeks in one year20
Trend breadth38.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.26Latest activity-pressure read.
Pressure change829.6%Four-week change in activity pressure.
Leadership59.44Latest relative-leadership reading.
RS change2748.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment51/100
Weighted news tone is neutral across 20 relevant articles.
2 positive · 17 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-0.2%Distance below the 52-week high.
13-week volatility11.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2610 weeks finished lower.
Best week+27.2%Week of 7 Aug.
Worst week-9.4%Week of 19 Jun.
Latest week+27.2%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains6
Flat weeks2
Modest losses4
Sharp losses6
Recent vol11.4%13-week weekly-return volatility.
Base vol7.7%52-week weekly-return volatility.
Up/down split24/26Count of positive and negative weeks in the 52-week window.
Average skew6.8% / -4.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorHK Healthcare
4-week rank2 / 100
Group average4.4%
Trend breadth12.0%
Trend12.0%active weekly trend signals
MD32.0%positive activity pressure
RS19.0%positive relative leadership
Four-week leaders
IndustryHK Biotechnology
4-week rank1 / 77
Group average2.4%
Trend breadth14.3%
Trend14.3%active weekly trend signals
MD24.7%positive activity pressure
RS20.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape66/100
Trend, activity pressure, participation, and risk combine to a 66/100 tape read.
Indicator analysis53/100Latest 12-week confirmation: trend 5/12, activity pressure 12/12, relative leadership 5/12.
Activity pressure 0.38; 1 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment51/100Weighted news tone is neutral across 20 relevant articles.
Genscript Biotech (1548) Q2 2025 Earnings Report - Results, Call & Slides Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 22.98 HKD | 27.2% | 13.42 HKD | 14.16 HKD | 1.26 | 59.44 | 248.6M | On |
| 31 Jul 2026 | 18.06 HKD | 12.2% | 13.13 HKD | 14.14 HKD | 0.95 | 25.17 | 151.6M | On |
| 24 Jul 2026 | 16.10 HKD | 21.8% | 12.96 HKD | 14.15 HKD | 0.58 | 15.79 | 149.5M | On |
| 17 Jul 2026 | 13.22 HKD | -4.5% | 12.86 HKD | 14.18 HKD | 0.13 | -3.57 | 119.9M | On |
| 10 Jul 2026 | 13.84 HKD | 1.7% | 12.86 HKD | 14.21 HKD | 0.14 | 2.09 | 78.5M | On |
| 3 Jul 2026 | 13.61 HKD | 15.4% | 12.84 HKD | 14.23 HKD | 0.20 | 3.77 | 18.0M | Off |
| 26 Jun 2026 | 11.79 HKD | 0.0% | 12.89 HKD | 14.25 HKD | 0.21 | -7.57 | 12.7M | Off |
| 19 Jun 2026 | 11.79 HKD | -9.4% | 13.00 HKD | 14.29 HKD | 0.63 | -12.64 | 115.0M | Off |
| 12 Jun 2026 | 13.02 HKD | 0.8% | 13.10 HKD | 14.33 HKD | 0.71 | -7.01 | 67.7M | Off |
| 5 Jun 2026 | 12.92 HKD | -5.6% | 13.24 HKD | 14.37 HKD | 0.82 | -9.10 | 12.1M | Off |
| 29 May 2026 | 13.68 HKD | 5.5% | 13.35 HKD | 14.41 HKD | 1.19 | -4.91 | 79.3M | Off |
| 22 May 2026 | 12.97 HKD | -7.8% | 13.43 HKD | 14.44 HKD | 1.07 | -11.36 | 47.5M | Off |
| 15 May 2026 | 14.06 HKD | -7.6% | 13.53 HKD | 14.47 HKD | 1.18 | -5.27 | 54.9M | Off |
| 8 May 2026 | 15.21 HKD | 10.9% | 13.58 HKD | 14.51 HKD | 1.12 | 1.16 | 66.8M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.